Literature DB >> 9234683

tau4/tau c/AF-2 of the thyroid hormone receptor relieves silencing of the retinoic acid receptor silencer core independent of both tau4 activation function and full dissociation of corepressors.

A Baniahmad1, D Thormeyer, R Renkawitz.   

Abstract

Members of the thyroid hormone (TR)-retinoic acid receptor (RAR) subfamily of nuclear hormone receptors silence gene expression in the absence of hormone. Addition of cognate ligands leads to dissociation of corepressors, association of coactivators, and transcriptional activation. Here, we used the hRAR alpha silencer core, which encompasses the ligand binding domain, including receptor regions D and E of RAR alpha without the activation function called tau4/tau c/AF-2 and without the F region, to analyze the mechanisms by which transcriptional silencing is relieved. Although the RAR silencer core is able to bind ligand, it acts as a constitutive transcriptional silencer. We have fused various small activation domains to the C terminus of the silencer core and analyzed hormone-dependent changes in receptor function. We show that nine amino acids derived from the hTRbeta are sufficient to transform the RAR silencer core into a hormone-dependent activator. Lengthening the linker between the silencer core and these nine amino acids is not critical for mediating ligand-induced relief of silencing and activation. In addition, we show that a transactivation function at the C terminus is not required for relief of silencing by the hormone, but it is required for transcriptional activation. Furthermore, we created functional silencer fusions which lose their repressive function upon addition of hormone, although the corepressors SMRT and N-CoR remain attached to the receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234683      PMCID: PMC232279          DOI: 10.1128/MCB.17.8.4259

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing.

Authors:  A Baniahmad; X Leng; T P Burris; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

2.  Ligand modulates the interaction of thyroid hormone receptor beta with the basal transcription machinery.

Authors:  G X Tong; M R Tanen; M K Bagchi
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

3.  Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha.

Authors:  W Bourguet; M Ruff; P Chambon; H Gronemeyer; D Moras
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

4.  Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor.

Authors:  J W Lee; H S Choi; J Gyuris; R Brent; D D Moore
Journal:  Mol Endocrinol       Date:  1995-02

5.  Structure of the carboxy-terminal region of thyroid hormone nuclear receptors and its possible role in hormone-dependent intermolecular interactions.

Authors:  M K Bhat; P McPhie; Y T Ting; X G Zhu; S Y Cheng
Journal:  Biochemistry       Date:  1995-08-22       Impact factor: 3.162

6.  Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region.

Authors:  X Leng; J Blanco; S Y Tsai; K Ozato; B W O'Malley; M J Tsai
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

7.  Distinct binding determinants for 9-cis retinoic acid are located within AF-2 of retinoic acid receptor alpha.

Authors:  B F Tate; G Allenby; R Janocha; S Kazmer; J Speck; L J Sturzenbecker; P Abarzúa; A A Levin; J F Grippo
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

8.  Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity.

Authors:  B Durand; M Saunders; C Gaudon; B Roy; R Losson; P Chambon
Journal:  EMBO J       Date:  1994-11-15       Impact factor: 11.598

9.  Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor.

Authors:  D Barettino; M M Vivanco Ruiz; H G Stunnenberg
Journal:  EMBO J       Date:  1994-07-01       Impact factor: 11.598

10.  Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor.

Authors:  V Cavaillès; S Dauvois; F L'Horset; G Lopez; S Hoare; P J Kushner; M G Parker
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

View more
  4 in total

1.  Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily.

Authors:  U Dressel; D Thormeyer; B Altincicek; A Paululat; M Eggert; S Schneider; S P Tenbaum; R Renkawitz; A Baniahmad
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  Multiple receptor interaction domains of GRIP1 function in synergy.

Authors:  S Schmidt; A Baniahmad; M Eggert; S Schneider; R Renkawitz
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

3.  Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras.

Authors:  Frauke Goeman; Dorit Thormeyer; Maria Abad; Manuel Serrano; Oliver Schmidt; Ignacio Palmero; Aria Baniahmad
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

Review 4.  Retinoic Acid Receptors in Acute Myeloid Leukemia Therapy.

Authors:  Orsola di Martino; John S Welch
Journal:  Cancers (Basel)       Date:  2019-12-01       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.